Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 2.1% – What’s Next?
by Doug Wharley · The Cerbat GemShares of Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) dropped 2.1% during mid-day trading on Thursday . The stock traded as low as $2.30 and last traded at $2.30. Approximately 1,500 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 3,400 shares. The stock had previously closed at $2.35.
Mayne Pharma Group Stock Performance
The firm’s 50-day simple moving average is $2.20 and its 200 day simple moving average is $1.87.
Mayne Pharma Group Company Profile
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.